Artificial Intelligence in Image-Based Screening, Diagnostics, and Clinical Care of Cardiopulmonary Diseases

Cardiothoracic and pulmonary diseases are a significant cause of mortality and morbidity worldwide. The COVID-19 pandemic has highlighted the lack of access to clinical care, the overburdened medical system, and the potential of artificial intelligence (AI) in improving medicine. There are a variety of diseases affecting the cardiopulmonary system including lung cancers, heart disease, tuberculosis (TB), etc., in addition to COVID-19-related diseases. Screening, diagnosis, and management of cardiopulmonary diseases has become difficult owing to the limited availability of diagnostic tools and experts, particularly in resource-limited regions. Early screening, accurate diagnosis and staging of these diseases could play a crucial role in treatment and care, and potentially aid in reducing mortality. Radiographic imaging methods such as computed tomography (CT), chest X-rays (CXRs), and echo ultrasound (US) are widely used in screening and diagnosis. Research on using image-based AI and machine learning (ML) methods can help in rapid assessment, serve as surrogates for expert assessment, and reduce variability in human performance. In this Special Issue, “Artificial Intelligence in Image-Based Screening, Diagnostics, and Clinical Care of Cardiopulmonary Diseases”, we have highlighted exemplary primary research studies and literature reviews focusing on novel AI/ML methods and their application in image-based screening, diagnosis, and clinical management of cardiopulmonary diseases. We hope that these articles will help establish the advancements in AI

A design of Convolutional Neural Network model for the Diagnosis of the COVID-19

With the spread of COVID-19 around the globe over the past year, the usage of artificial intelligence (AI) algorithms and image processing methods to analyze the X-ray images of patients' chest with COVID-19 has become essential. The COVID-19 virus recognition in the lung area of a patient is one of the basic and essential needs of clicical centers and hospitals. Most research in this field has been devoted to papers on the basis of deep learning methods utilizing CNNs (Convolutional Neural Network), which mainly deal with the screening of sick and healthy people.In this study, a new structure of a 19-layer CNN has been recommended for accurately recognition of the COVID-19 from the X-ray pictures of chest. The offered CNN is developed to serve as a precise diagnosis system for a three class (viral pneumonia, Normal, COVID) and a four classclassification (Lung opacity, Normal, COVID-19, and pneumonia). A comparison is conducted among the outcomes of the offered procedure and some popular pretrained networks, including Inception, Alexnet, ResNet50, Squeezenet, and VGG19 and based on Specificity, Accuracy, Precision, Sensitivity, Confusion Matrix, and F1-score. The experimental results of the offered CNN method specify its dominance over the existing published procedures. This method can be a useful tool for clinicians in deciding properly about COVID-19

A novel augmented deep transfer learning for classification of COVID-19 and other thoracic diseases from X-rays

Deep learning has provided numerous breakthroughs in natural imaging tasks. However, its successful application to medical images is severely handicapped with the limited amount of annotated training data. Transfer learning is commonly adopted for the medical imaging tasks. However, a large covariant shift between the source domain of natural images and target domain of medical images results in poor transfer learning. Moreover, scarcity of annotated data for the medical imaging tasks causes further problems for effective transfer learning. To address these problems, we develop an augmented ensemble transfer learning technique that leads to significant performance gain over the conventional transfer learning. Our technique uses an ensemble of deep learning models, where the architecture of each network is modified with extra layers to account for dimensionality change between the images of source and target data domains. Moreover, the model is hierarchically tuned to the target domain with augmented training data. Along with the network ensemble, we also utilize an ensemble of dictionaries that are based on features extracted from the augmented models. The dictionary ensemble provides an additional performance boost to our method. We first establish the effectiveness of our technique with the challenging ChestXray-14 radiography data set. Our experimental results show more than 50% reduction in the error rate with our method as compared to the baseline transfer learning technique. We then apply our technique to a recent COVID-19 data set for binary and multi-class classification tasks. Our technique achieves 99.49% accuracy for the binary classification, and 99.24% for multi-class classification

Automated Lung Disease Detection and Classification Using Quantum Glowworm Swarm Optimizer with Quasi Recurrent Neural Network on Chest X-Ray Images

Lung diseases or otherwise called respiratory diseases are airborne diseases that affect the lungs and the other tissues of the lungs. Tuberculosis, Coronavirus Disease 2019 (COVID-19), and Pneumonia are a few instances of lung diseases. If the lung disease is diagnosed and treated in the initial stage, the chances of recovery rate and long-term survival rates can be increased. Usually, lung disease is identified by Chest X-Ray (CXR) image examination, skin test, sputum sample test, Computed Tomography (CT) scan examination, and blood test. Because of its non-invasive and convenient evaluation for overall outcomes of the chest situation, Lung disease can be detected by specialized radiologists on CXR images. In recent times, Deep Learning (DL) applies to medical images for disease detection and has proved an effective technique for detecting disease. The recent advancement of DL supports the detection and classification of lung diseases in medicinal imaging. This article presents an Automated Lung Disease Detection Using Quantum Glowworm Swarm Optimization with Quasi Recurrent Neural Network (QGSO-QRNN) model on CXR imaging. The presented QGSO-QRNN technique focuses on the identification of lung diseases using DL concepts. To accomplish this, the presented QGSO-QRNN technique initially performs image pre-processing by the use of the Gaussian Filtering (GF) technique. Besides, the Faster SqueezeNet approach is exploited for feature vector generation. Finally, the QRNN model is applied for precise classification of lung diseases with the QGSO technique as a hyperparameter optimizer. The investigational assessment of the QGSO-QRNN technique is examined by employing standard medical datasets and the outputs display the promising performance of the QGSO-QRNN technique over other existing techniques by means of diverse measures

A real time method for distinguishing COVID-19 utilizing 2D-CNN and transfer learning

Rapid identification of COVID-19 can assist in making decisions for effective treatment and epidemic prevention. The PCR-based test is expert-dependent, is time-consuming, and has limited sensitivity. By inspecting Chest R-ray (CXR) images, COVID-19, pneumonia, and other lung infections can be detected in real time. The current, state-of-the-art literature suggests that deep learning (DL) is highly advantageous in automatic disease classification utilizing the CXR images. The goal of this study is to develop models by employing DL models for identifying COVID-19 and other lung disorders more efficiently. For this study, a dataset of 18,564 CXR images with seven disease categories was created from multiple publicly available sources. Four DL architectures including the proposed CNN model and pretrained VGG-16, VGG-19, and Inception-v3 models were applied to identify healthy and six lung diseases (fibrosis, lung opacity, viral pneumonia, bacterial pneumonia, COVID-19, and tuberculosis). Accuracy, precision, recall, f1 score, area under the curve (AUC), and testing time were used to evaluate the performance of these four models. The results demonstrated that the proposed CNN model outperformed all other DL models employed for a seven-class classification with an accuracy of 93.15% and average values for precision, recall, f1-score, and AUC of 0.9343, 0.9443, 0.9386, and 0.9939. The CNN model equally performed well when other multiclass classifications including normal and COVID-19 as the common classes were considered, yielding accuracy values of 98%, 97.49%, 97.81%, 96%, and 96.75% for two, three, four, five, and six classes, respectively. The proposed model can also identify COVID-19 with shorter training and testing times compared to other transfer learning models